Keywords: اینترلوکین; ACN; acetonitrile; BTP-M; black-tea-process-mature; CQAs; caffeoylquninic acid; 3-CQA; 3-caffeoylquninic acid; 4-CQA; 4-caffeoylquninic acid; 5-CQA; 5-caffeoylquninic acid; COX-2; cyclooxygenase 2; 3,4-diCQA; 3,4-dicaffeoylquninic acid; 3,5-diCQA; 3,5-dic
مقالات ISI اینترلوکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین; Ulcerative colitis; Crohn's disease; Infliximab; Loss of response; Adsorptive granulocyte/monocyte apheresis; CD; Crohn's disease; CRP; C-reactive protein; GMA; granulocyte/monocyte apheresis; IL; interleukin; LOR; loss of response; TI; trough inflixi
Keywords: اینترلوکین; ILC; innate lymphoid cell; IFN; interferon; IL; interleukin; IL-1R8; interleukin-1 receptor 8; LDTF; lineage defining TF; LTi; lymphoid tissue inducer; NMU; neuromedin U; NCR; natural cytotoxicity receptor; NK; natural Killer; NGS; next generation sequenc
Keywords: اینترلوکین; alopecia areata; psoriasis; Renbök phenomenon; trichoscopy; AA; alopecia areata; CI; confidence interval; IL; interleukin; OR; odds ratio; PsA; psoriatic arthritis; Th; T helper; TNF; tumor necrosis factor;
Keywords: اینترلوکین; CECs; Cerebral Endothelial Cells; HE; Hepatic Encephalopathy; IL; Interleukin; LPS; Lipopolysaccharide; MPA; Monocyte Platelet Aggregate; PSGL-1; Anti-P-Selectin Glycoprotein 1; QoL; Quality of Life; SIBO; Small Intestinal Bacterial Overgrowth; TNF-α; Tu
Keywords: اینترلوکین; hyperpigmentation; lentigines; macules; plaque psoriasis; ELRP; eruptive lentiginosis in resolving psoriatic plaques; IL; interleukin; TNF; tumor necrosis factor;
Keywords: اینترلوکین; Asthma; Blood eosinophils; Eosinophilia; Exhaled nitric oxide; Prospective study; AUC; area under the curve; CI; confidence interval; FeNO; fraction of exhaled nitric oxide; IL; interleukin; NPV; negative predictive value; PPV; positive predictive value;
Keywords: اینترلوکین; Immune privilege; CD47; CD274; Cytokine levels; Bone marrow; Stem cells; allo-HSCT; allogeneic hematopoietic stem cell transplantation; G-CSF; granulocyte - colony stimulating factor; PBSCs; peripheral blood stem cells; GVHD; graft-versus-host disease; cG
Keywords: اینترلوکین; AA; amino acid; GI; gastrointestinal; HC; healthy control; IL; interleukin; FIV; feline immunodeficiency virus; FeLV; feline leukemia virus; FCEAI; feline chronic enteropathy activity index; SAA; serum amyloid A; BCS; body condition score; EAA; essential
Keywords: اینترلوکین; BC-TA; crestal bone to tooth apex; BHI; Brain Heart Infusion; CEJ; cemento-enamel junction; FAA; Fastidious Anaerobe Agar; FAB; Fastidious Anaerobe Broth; ICC; intra-class correlation coefficient; Ig; immunoglobulin; IL; interleukin; RANK-L; receptor acti
Keywords: اینترلوکین; Aortic dissection; Cytokines; Interleukin; Interferon; Tumor necrosis factor; Colony stimulating factor; Chemokine and growth factor;
Keywords: اینترلوکین; hyperpigmentation; lentigines; macules; plaque; psoriasis; ELRP; eruptive lentiginosis in resolving psoriatic plaques; IL; interleukin; TNF; tumor necrosis factor;
Keywords: اینترلوکین; Kasai-procedure; Long term outcome; Liver cirrhosis; LTx; Inflammatory milieu; BA; biliary atresia; BARD; Biliary Atresie and Related Diseases; Beta-NGF; beta-nerve growth factor; Beta-FGF; beta Fibroblast growth factor; BDNF; brain-derived neurotrophic f
Keywords: اینترلوکین; Infants; Periostin; Respiratory syncytial virus; Squamous cell carcinoma antigen; T-helper 2 cell cytokines; SCCA; squamous cell carcinoma antigen; RSV; respiratory syncytial virus; mAPI; modified Asthma Predictive Index; Th 2; T-helper 2; IL; interleukin
Keywords: اینترلوکین; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
Keywords: اینترلوکین; AD; atopic dermatitis; BEEP; Barrier Enhancement for Eczema Prevention; BPA; bisphenol A; CDC; Center for Disease Control and Prevention; DBP; vitamin D binding protein; IL; interleukin; Ig; immunoglobulin; FLG; filaggrin; FDA; Food and Drug Administratio
Keywords: اینترلوکین; Cultured decidua-derived mast cells; Decidua; FcεRI; Mast cell; Pregnancy; Ab; antibody; CB; cord blood; EIA; enzyme immunoassay; EM; electron microscopic analyses; IL; interleukin; IMDM; Iscove's modified Dulbecco's medium; m; monoclonal; MCs; mast cell
Keywords: اینترلوکین; Aneurisma de aorta abdominal; Inflamación; Interleucina; Abdominal aortic aneurysm; Inflammation; Interleukin;
Keywords: اینترلوکین; CGM; Continuous glucose monitoring; GLUT4; Glucose transporter 4; MET; Metabolic equivalent task; IL; Interleukin; TNF; Tumour necrosis factor; Sedentary lifestyle; Physical activity; Glucose; Type 2 diabetes;
Keywords: اینترلوکین; AD; atopic dermatitis; DLQI; dermatology life quality index; EASI; eczema area and severity index; IFN; interferon; IL; interleukin; KFDA; korea food and drug administration; SCORAD; SCORing AD; TEWL; transepidermal water loss; Atopic dermatitis; Topical
Keywords: اینترلوکین; AMPK; AMP-activated protein kinase; COX-2; cyclooxegenase-2; DAI; disease activity index; DSS; dextran sulfate sodium; IBD; inflammatory bowel disease; IL; interleukin; NF-κB; nuclear factor kappa light-chain-enhancer of activated B cells; RB; red raspbe
Keywords: اینترلوکین; AAS; atomic absorption spectrometry; IL; interleukin; LPS; lipopolysaccharide; MT; metallothionein; MM1; Mono Mac 1; TNF; tumor necrosis factor; TPEN; N,N,Nâ²,Nâ²-tetrakis(2-pyridylmethyl)ethylenediamine; Zinc deficiency; Calprotectin; Myeloid cells; Mo
Keywords: اینترلوکین; CCK; cholecystokinin; CGRP; calcitonin gene-related peptide; DAB; diaminobenzidine; DCLK1; doublecortin-like kinase 1; HTX; hematoxylin; IL; interleukin; IR; immunoreactive; GI; gastrointestinal; GLP-1; glucagon like peptide-1; LI; large intestine; PBS-T;
Keywords: اینترلوکین; Ang II; angiotensin II; BSA; bovine serum albumin; INF; interferon; IL; interleukin; MPO; myeloperoxidase; NAG; N-acetyl-β-D-glucosaminidase; PCNA; proliferating cell nuclear antigen; RAS; renin-angiotensin System; TNF; tumor necrosis factor; Psoriasis;
Keywords: اینترلوکین; TSLP; thymic stromal lymphopoietin; TSLPR; TSLP receptor; iNKT; invariant natural killer T cell; TH; CD4+ T helper cell; ILC2; group 2 innate lymphoid cell; Ig; immunoglobulin; IFN; interferon; IL; interleukin; HMGB1; high-mobility group box 1 protein; PR
Keywords: اینترلوکین; M.tb; Mycobacterium tuberculosis; AT; alveolar epithelial cell; ALF; alveolar lining fluid; TB; tuberculosis; P-L; phagosome - lysosome; SP-A; surfactant protein - A; SP-D; surfactant protein - D; IL; interleukin; MHC; major histocompatibility complex; TL
Keywords: اینترلوکین; type 1 diabetes; diabetic kidney disease; social determinants; ACR; Albumin:creatinine ratio; AdDIT; Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial; BMI; Body mass index; eGFR; Estimated glomerular filtration rate; GFR; Glomerular filtration r
Keywords: اینترلوکین; AP; Alkaline phosphatase; BA; Biliary atresa; BASM; Biliary atresia splenic malformation; CMV; Cytomegalovirus; DDT; Duodenal tube test; EHBDs; Extrahepatic biliary ducts; ERCP; Endoscopic retrograde cholangiopancreatography; GB; Gallbladder; GGT; Gamma-g
Keywords: اینترلوکین; IL; interleukin; S. aureus; Staphylococcus aureus; CRSwNP; chronic rhinosinusitis with nasal polyps (nasal polyps); MALDI-MS; matrix-assisted laser desorption ionization mass spectrometry; ISP; Intravenous Staphylococcal Phage; ECP; eosinophil-cationic pr
Keywords: اینترلوکین; asimadoline; atopic dermatitis; emerging agents; fezakinumab; hypocholrous acid; omiganan; secukinumab; tapinarof; AD; atopic dermatitis; AE; adverse effect; AhR; aryl hydrocarbon receptor; AMP; antimicrobial peptide; EFA; essential fatty acids; HOCl; hyp
Keywords: اینترلوکین; AT1-AA; angiotensin II type 1 receptor agonistic autoantibodies; ATF; activating transcription factor; CH; chronic hypertension; dNK; decidual NK cell; ECM; extracellular matrix; eIF2a; eukaryotic initiation factor 2 subunit a; ER; endoplasmatic reticulum
Keywords: اینترلوکین; Genetic; interleukin; periapical abscess; periapical periodontitis; polymorphism;
Keywords: اینترلوکین; Microbiota; Fructose; Inflammation; Wheat bran; Enterobacteriaceae; AMP; Antimicrobial peptides; AX; Arabinoxylan; CD; Clusters of differentiation; IFN-γ; Interferon gamma; IL; Interleukin; LPS; Lipopolysaccharides; MCP1; Monocyte chemotactic protein 1;
Keywords: اینترلوکین; ACEI; angiotensin converting enzyme inhibitor; ADHD; attention deficit hyperactivity disorder; Ang; angiotensin; AT1R; angiotensin type 1 receptor; AT2R; angiotensin type 2 receptor; CNS; central nervous system; CVLM; caudal ventrolateral medulla; IL; int
Keywords: اینترلوکین; ADC; arginine decarboxylase; ADI; arginine deiminase; ADI-PEG20; ADI- polyethylene glycol 20; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; Arg; arginine; ASL; argininosuccinate lyase; Asn; asparagine; ASS1; argininosuccinate synthas
Keywords: اینترلوکین; aCEase; acid-ceramidase; β-GlcCer'ase; β-glucocerebrosidase; EDTA; ethylenediaminetetraacetic acid; FLG; filaggrin; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; IL; interleukin; IVL; involucrin; LOR; loricrin; mRNA; messenger RNA; NHKs; normal hum
Keywords: اینترلوکین; CD; Crohn's disease; DAI; disease activity index; DSS; dextran sodium sulfate; ELISA; enzyme-linked immunosorbent assay; FBS; fetal bovine serum; H&E; hematoxylin & eosin; IBD; inflammatory bowel disease; IL; interleukin; PMA; phorbol 12-myristate 13-acet
Keywords: اینترلوکین; Aβ; amyloid-β-peptide; ACh; acetylcholine; Apo; apolipoprotein; APP; amyloid precursor protein; CYP; cytochrome P-450; DYRK1; dual specificity tyrosine-phosphorylation-regulated kinase 1A; GABA; γ-aminobutyric acid; GSK; glycogen synthase- kinase; HSV-
Keywords: اینترلوکین; B. mix; mixture of B. animalis subsp. lactis Bi1, B. breve Bbr8 and B. breve BL10; CFU; colony forming units; HFD; high fat diet; IFN; interferon; IL; interleukin; La; L. acidophilus LA1/K8; LGG; Lactobacillus rhamnosus GG; LS; mixture of L. delbrueckii s
Keywords: اینترلوکین; Theanine; Heat stress; Liver injury; Heat shock response; HPA axis; ACTH; adrenocorticotropic hormone; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CAT; catalase; CORT; glucocorticoids; COX-2; cyclooxygenase-2; CRP; C-reaction protein;
Keywords: اینترلوکین; Acute phase response; Corticosterone; Cytokine; Ecoimmunology; Interleukin;
Keywords: اینترلوکین; IBD; inflammatory bowel disease; DSS; dextran sulfate sodium; DML; donkey milk lysozyme; HEL; hen egg lysozyme; ZO-1; zonula occludens-1; MPO; myeloperoxidase; TJ; tight junction; TNF-α; tumour necrosis factor-α; IL; interleukin; PCoA; principal co-ordi
Keywords: اینترلوکین; CAT; Catalase; DAI; Disease activity index; DSS; Dextran sulfate sodium; ELISA; Enzyme linked immunoassay; IBD; Inflammatory bowel disease; IL; Interleukin; α-LA; Alpha-lipoic acid; MDA; Malondialdehyde; NF-κB; Nuclear factor-kappa-B; PBS-BSA; Phosphate
Keywords: اینترلوکین; adiposity; fetal programming; pregnancy; dietary inflammatory index; inflammation; ASA24; Automated Self-Administered 24-hour Dietary Recall; BMI; Body mass index; CRP-hs; High-sensitivity C-reactive protein; DII; Dietary inflammatory index; IL; Interleuk
Keywords: اینترلوکین; C3aR; C3a receptor; C5aR1/2; C5a receptor 1/2; CLP; cecal ligation and puncture; CXCR4; C-X-C chemokine receptor type 4; DAMPs/PAMPs; damage-/pathogen-associated molecular patterns; Efb; extracellular fibrinogen-binding protein; ERK; extracellular signal-
Keywords: اینترلوکین; A; asymptomatic patients (without ischemic event); CEA; carotid endarterectomies; ECs; endothelial cells; oxLDL; oxidized low-density lipoprotein; S; symptomatic patients (suffering ischemic event); SMCs; smooth muscle cells; Carotid; Atherosclerosis; Smo
Keywords: اینترلوکین; APC; allophycocyanin; aMEM; medium eagle alpha modification; ANOVA; one-way analysis of variance; BALF; bronchoalveolar lavage fluid; bFGF; basic fibroblast growth factor; BM-MSC; bone marrow-derived mesenchymal stem cell; Ccl; chemokine (C-C motif) ligan
Keywords: اینترلوکین; COX-2; cyclooxygenase-2; DOCA; deoxycorticosterone acetate; FOX1; ferrous ion oxidation by xylenol orange reagent; FRAP; ferric reducing antioxidant power; H & E; hematoxylin and eosin; H2O2; hydrogen peroxide; IL; interleukin; MDA; malondialdehyde; NADPH
Keywords: اینترلوکین; Insulin; C-peptide; IGF-1; Body composition; 1-RM; 1 Repetition Maximum; ADT; Androgen Deprivation Therapy; AUC; Area Under the Curve; BMI; Body Mass Index; CRP; C-reactive Protein; CVD; Cardiovascular Disease; DBP; Diastolic Blood Pressure; FFM; Fat Free
Keywords: اینترلوکین; ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-